Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects

被引:155
作者
Ellard, Sian
Flanagan, Sarah E.
Girard, Christophe A.
Patch, Ann-Marie
Harries, Lorna W.
Parrish, Andrew
Edghill, Emma L.
Mackay, Deborah J. G.
Proks, Peter
Shimomura, Kenju
Haberland, Holger
Carson, Dennis J.
Shield, Julian P. H.
Hattersley, Andrew T.
Ashcroft, Frances M.
机构
[1] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England
[2] Univ Oxford, Physiol Lab, Oxford OX1 2JD, England
[3] Salisbury Dist Hosp, Wessex Reg Genet Labs, Salisbury, Wilts, England
[4] Sana Klinikum Lichtenberg, Dept Paediat, Berlin, Germany
[5] Queens Univ Belfast, Dept Child Hlth, Belfast BT7 1NN, Antrim, North Ireland
[6] Univ Bristol, Bristol BS8 1TH, Avon, England
[7] Bristol Royal Hosp Children, Bristol, Avon, England
基金
英国惠康基金;
关键词
D O I
10.1086/519174
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Heterozygous activating mutations in the KCNj11 gene encoding the pore-forming Kir6.2 subunit of the pancreatic beta cell KAT, channel are the most common cause of permanent neonatal diabetes (PNDM). Patients with PNDM due to a heterozygous activating mutation in the ABCC8 gene encoding the SUR1 regulatory subunit of the K-ATP, channel have recently been reported. We studied a cohort of 59 patients with permanent diabetes who received a diagnosis before 6 mo of a-e and who did not have a KCNJ11 mutation. ABCC8 gene mutations were identified in 16 of 59 patients and included 8 patients with heterozygous de novo mutations. A recessive mode of inheritance was observed in eight patients with homozygous, mosaic, or compound heterozygous mutations. Functional studies of selected mutations showed a reduced response to ATP consistent with an activating mutation that results in reduced insulin secretion. A novel mutational mechanism was observed in which a heterozygous activating mutation resulted in PNDM only when a second, loss-of-function mutation was also present.
引用
收藏
页码:375 / 382
页数:8
相关论文
共 20 条
  • [1] From molecule to malady
    Ashcroft, FM
    [J]. NATURE, 2006, 440 (7083) : 440 - 447
  • [2] Activating mutations in the ABCC8 gene in neonatal diabetes mellitus
    Babenko, Andrey P.
    Polak, Michel
    Cave, Helene
    Busiah, Kanetee
    Czernichow, Paul
    Scharfmann, Raphael
    Bryan, Joseph
    Aguilar-Bryan, Lydia
    Vaxillaire, Martine
    Froguel, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (05) : 456 - 466
  • [3] Codner Ethel, 2007, Diabetes Care, V30, pe28, DOI 10.2337/dc06-2134
  • [4] Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype
    Flanagan, SE
    Edghill, EL
    Gloyn, AL
    Ellard, S
    Hattersley, AT
    [J]. DIABETOLOGIA, 2006, 49 (06) : 1190 - 1197
  • [5] CROSS-SECTIONAL STATURE AND WEIGHT REFERENCE CURVES FOR THE UK 1990
    FREEMAN, JV
    COLE, TJ
    CHINN, S
    JONES, PRM
    WHITE, EM
    PREECE, MA
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (01) : 17 - 24
  • [6] Glucokinase (GCK) mutations in hyper- and hypoglycemia:: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy
    Gloyn, AL
    [J]. HUMAN MUTATION, 2003, 22 (05) : 353 - 362
  • [7] Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
    Gloyn, AL
    Pearson, ER
    Antcliff, JF
    Proks, P
    Bruining, GJ
    Slingerland, AS
    Howard, N
    Srinivasan, S
    Silva, JMCL
    Molnes, J
    Edghill, EL
    Frayling, TM
    Temple, IK
    Mackay, D
    Shield, JPH
    Sumnik, Z
    van Rhijn, A
    Wales, JKH
    Clark, P
    Gorman, S
    Aisenberg, J
    Ellard, S
    Njolstad, PR
    Ashcroft, FM
    Hattersley, AT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) : 1838 - 1849
  • [8] GRIBBLE RM, 1997, EMBO J, V16, P1145
  • [9] Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene
    Hansen, T
    Echwald, SM
    Hansen, L
    Moller, AM
    Almind, K
    Clausen, JO
    Urhammer, SA
    Inoue, H
    Ferrer, J
    Bryan, J
    Aguilar-Bryan, L
    Permutt, MA
    Pedersen, O
    [J]. DIABETES, 1998, 47 (04) : 598 - 605
  • [10] Activating mutations in Kir6.2 and neonatal diabetes - New clinical syndromes, new scientific insights, and new therapy
    Hattersley, AT
    Ashcroft, FM
    [J]. DIABETES, 2005, 54 (09) : 2503 - 2513